Florian Hoss

Florian Hoss is a Principal Scientist at Odyssey Therapeutics since May 2022, previously holding the position of Senior Scientist. Prior experience includes a role as Senior Scientist and Scientist at IFM Therapeutics from October 2019 to May 2022, and a Postdoctoral Research Associate and PhD Student at The University of Bonn's Institute of Innate Immunity from August 2013 to October 2019. Additionally, Florian Hoss interned at Bayer in March 2013. Educational qualifications include a Doctor of Philosophy (PhD) in Innate Immunity and a Master of Science (MS) in Life and Medical Sciences from The University of Bonn, as well as a Bachelor of Science (BS) in Molecular Biomedicine, all completed between 2008 and 2019.